Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
05/12/2004 | CN1149200C 2-[(dihydro)pyrazole-3'-oxymethoylene]aniline amide and its preparation and use |
05/12/2004 | CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas |
05/11/2004 | US6733905 Metal coordination compound, luminescence device and display apparatus |
05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
05/06/2004 | WO2004037798A1 Nitric oxide releasing selective cyclooxygenase-2 inhibitors |
05/06/2004 | WO2004037794A1 Process for making pyrazole compounds |
05/06/2004 | WO2004037793A1 Pyrazole-4-alkanoate derivatives inhibiting cyclooxygenase and 5-lipoxygenase |
05/06/2004 | WO2004037249A1 Agent for alleviation of functional disorder after cardiopulmonary resuscitation |
05/06/2004 | WO2004037248A2 Modulation of peroxisome proliferator activated receptors activity |
05/06/2004 | WO2003106416A3 Chemical process |
05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
05/06/2004 | US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size |
05/06/2004 | US20040087637 Antiserotonine agents; central nervous system disorders |
05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
05/06/2004 | US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands |
05/06/2004 | US20040087585 Peptide deformylase inhibitors |
05/06/2004 | US20040087584 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction |
05/06/2004 | US20040083558 Oxidation hair color dyes, with properties as bright, chromatic, weatherproofing, wash and wear, chemical resistance |
05/06/2004 | EP1415989A1 Synthesis of 3-acylaminopyrazoles |
05/06/2004 | EP1414815A1 Tetrahydropyridazine derivatives and their use as pesticides |
05/06/2004 | EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
05/06/2004 | EP1414804A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
05/06/2004 | EP1414803A1 Pyrazolylcarboxanilides as fungicides |
05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
05/06/2004 | EP1414522A2 Carbonic anhydrase inhibitors |
05/06/2004 | CA2503063A1 Nitric oxide releasing selective cyclooxygenase-2 inhibitors |
05/06/2004 | CA2503024A1 Process for making pyrazole compounds |
05/05/2004 | CN1494530A Heterocyclic diamide invertebrate pest control agents |
05/05/2004 | CN1148346C Hydrazine derivs. |
05/05/2004 | CN1148336C Nitrification inhibitors and use of polyacids to treat inorganic fertilizers contg. nitrification inhibitor |
05/04/2004 | US6730792 β3 adrenergic agonists |
05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
05/04/2004 | US6730684 Key regulatory point in the overall synthetic pathway of bacterial fatty acid biosynthesis; fabi is an ideal target for antibacterial intervention |
05/04/2004 | US6730151 Ink jet dye design |
04/29/2004 | WO2004035589A1 Heterocyclocarboxamide derivatives |
04/29/2004 | WO2004035545A2 Azolecarboxamide herbicides |
04/29/2004 | WO2004035048A1 Hepatic fibrosis inhibitor |
04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
04/29/2004 | US20040082625 Osteoporosis, bone disorders |
04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
04/29/2004 | US20040082571 Substituted piperazines |
04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
04/28/2004 | EP1413575A2 Process for preparing derivatives of [(1,5-diaryl)pyrazol-3-yl]propanoic acid |
04/28/2004 | EP1413305A1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence |
04/28/2004 | EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
04/28/2004 | EP1412334A1 Pyrazoline derivatives and their use as pesticides |
04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
04/28/2004 | EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
04/28/2004 | EP1083171B1 Pyrazoline derivatives, their preparation and application as medicaments |
04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
04/28/2004 | CN1147294C Pentafluorobenzenesulfonamides and analogs |
04/27/2004 | US6727273 Therapy for osteoporosis, anticancer agents |
04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
04/27/2004 | US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's |
04/22/2004 | WO2004033434A1 Pyrazole compounds for treatment of neurodegenerative disorders |
04/22/2004 | WO2004033433A1 Pyrazolone compounds and thrombopoietin receptor activator |
04/22/2004 | WO2004033432A1 Novel pyrazole compounds having antifungal activity |
04/22/2004 | WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity |
04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
04/22/2004 | WO2004032975A2 Biphenyls and fluorenes as imaging agents in alzheimer's disease |
04/22/2004 | WO2004032931A1 Method for treatment of cancer |
04/22/2004 | WO2004032928A1 5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia |
04/22/2004 | WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
04/22/2004 | WO2003078403A3 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase |
04/22/2004 | WO2003072541A3 Chemical compounds |
04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
04/22/2004 | US20040077855 Thrombopoietin mimetics |
04/22/2004 | US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease |
04/22/2004 | US20040077646 Indole nitriles |
04/22/2004 | US20040077019 Tagging compounds and process for use in aida libraries |
04/22/2004 | CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity |
04/22/2004 | CA2501134A1 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia |
04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
04/21/2004 | EP1408950A2 Methods of treating cytokine mediated diseases |
04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
04/21/2004 | CN1146560C Substituted benzoylpyrazoles as herbicides |
04/21/2004 | CN1146544C Pyrazoelcarboxylic acid derivatives, their preparation, pharmaceutical compositions containing |
04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
04/15/2004 | WO2004031203A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |